Reduced human and murine corneal thickness in an Axenfeld-Rieger syndrome subtype

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 11, 2006, Pages 4905-4909

  Asai Coakwell, Mika ^a   Backhouse, Christopher ^a   Casey, Ronald J ^a   Gage, Philip J ^b   Lehmann, Ordan J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASTIC; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALIBRATION; CONTROLLED STUDY; CORNEA THICKNESS; EYE DEVELOPMENT; FILM; FOXC1 GENE; GENE; GLAUCOMA; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PEDIGREE; PHENOTYPE; PITX2 GENE; PRIORITY JOURNAL; RIEGER SYNDROME; SCANNING ELECTROCHEMICAL MICROSCOPY; ULTRASONIC PACHYMETRY; ULTRASOUND; VISUAL SYSTEM EXAMINATION; ANIMAL; C57BL MOUSE; CONGENITAL MALFORMATION; CORNEA; ECHOGRAPHY; EYE MALFORMATION; GENETICS; MORPHOMETRICS; MUTATION; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; SYNDROME;

ANIMALS; BODY WEIGHTS AND MEASURES; CORNEA; EYE ABNORMALITIES; GLAUCOMA; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MUTATION; SYNDROME; TOMOGRAPHY, OPTICAL COHERENCE; TRANSCRIPTION FACTORS;

EID: 34247141933     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0457     Document Type: Article

References (38)

1. Quigley HA. Proportion of those with open-angle glaucoma who become blind. Ophthalmology. 1999;106:2039-2041.
2. Quigley HA, Congdon NG, Friedman DS. Glaucoma in China (and worldwide): changes in established thinking will decrease preventable blindness. Br J Ophthalmol. 2001;85:1271-1272.
3. Leskea MC, Heijl A, Hyman L, et al. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol. 2004;15:102-106.
4. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44:367-408.
5. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108:1779-1788.
6. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720; discussion 829-830.
7. Lee BL, Wilson MR. Ocular Hypertension Treatment Study (OHTS) commentary. Curr Opin Ophthalmol. 2003;14:74-77.
8. Lehmann OJ, Tuft S, Brice G, et al. Novel anterior segment phenotypes resulting from forkhead gene alterations: evidence for cross-species conservation of function. Invest Ophthalmol Vis Sci. 2003;44:2627-2633.
9. Ramaesh T, Collinson JM, Ramaesh K, et al. Corneal abnormalities in Pax6+/- small eye mice mimic human aniridia-related keratopathy. Invest Ophthalmol Vis Sci. 2003;44:1871-1878.
10. Brandt JD, Casuso LA, Budenz DL. Markedly increased central corneal thickness: an unrecognized finding in congenital aniridia. Am J Ophthalmol. 2004;137:348-350.
11. Blixt A, Mahlapuu M, Aitola M, et al. A forkhead gene, FoxE3, is essential for lens epithelial proliferation and closure of the lens vesicle. Genes Dev. 2000;14:245-254.
12. Brownell I, Dirksen M, Jamrich M. Forkhead Foxe3 maps to the dysgenetic lens locus and is critical in lens development and differentiation. Genesis. 2000;27:81-93.
13. Ormestad M, Blixt A, Churchill A, et al. Foxe3 haploinsufficiency in mice: a model for Peters' anomaly. Invest Ophthalmol Vis Sci. 2002;43:1350-1357.
14. Alward WL. Axenfeld-Rieger syndrome in the age of molecular genetics. Am J Ophthalmol. 2000;130:107-115.
15. Lines MA, Kozlowski K, Kulak SC, et al. Characterization and prevalence of PITX2 microdeletions and mutations in Axenfeld-Rieger malformations. Invest Ophthalmol Vis Sci. 2004;45:828-833.
16. Hjalt TA, Semina EV. Current molecular understanding of Axenfeld-Rieger syndrome. Expert Rev Mol Med. 2005;7:1-17.
17. Mears AJ, Jordan T, Mirzayans F, et al. Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet. 1998;63:1316-1328.
18. Nishimura DY, Swiderski RE, Alward WL, et al. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet. 1998;19:140-147.
19. Semina EV, Reiter RS, Murray JC. Isolation of a new homeobox gene belonging to the Pitx/Rieg family, expression during lens development and mapping to the aphakia region on mouse chromosome 19. Hum Mol Genet. 1997;6:2109-2116.
20. Jamieson RV, Perveen R, Kerr B, et al. Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. Hum Mol Genet. 2002;11:33-42.
21. Nishimura DY, Searby CC, Alward WL, et al. A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye. Am J Hum Genet. 2001;68:364-372.
22. Gould DB, Jaafar MS, Addison MK, et al. Phenotypic and molecular assessment of seven patients with 6p25 deletion syndrome: relevance to ocular dysgenesis and hearing impairment. BMC Med Genet. 2004;5:17.
23. Lehmann OJ, Ebenezer ND, Ekong R, et al. Ocular developmental abnormalities and glaucoma associated with interstitial 6p25 duplications and deletions. Invest Ophthalmol Vis Sci. 2002;43:1843-1849.
24. Lehmann OJ, Ebenezer ND, Jordan T, et al. Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet. 2000;67:1129-1135.
25. Kume T, Deng KY, Winfrey V, et al. The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus. Cell. 1998;93:985-996.
26. Gage PJ, Rhoades W, Prucka SK, Hjalt T. Fate maps of neural crest and mesoderm in the mammalian eye. Invest Ophthalmol Vis Sci. 2005;46:4200-4208.
27. Gage PJ, Suh H, Camper SA. Dosage requirement of Pitx2 for development of multiple organs. Development. 1999;126:4643-4651.
28. Gage PJ, Suh H, Camper SA. The bicoid-related Pitx gene family in development. Mamm Genome. 1999;10:197-200.
29. Walter MA, Mirzayans F, Mears AJ, et al. Autosomal-dominant iridogoniodysgenesis and Axenfeld-Rieger syndrome are genetically distinct. Ophthalmology. 1996;103:1907-1915.
30. Kulak SC, Kozlowski K, Semina EV, et al. Mutation in the RIEG1 gene in patients with iridogoniodysgenesis syndrome. Hum Mol Genet. 1998;7:1113-1117.
31. Kozlowski K, Walter MA. Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders. Hum Mol Genet. 2000;9:2131-2139.
32. Holmberg J, Liu CY, Hjalt TA. PITX2 gain-of-function in Rieger syndrome eye model. Am J Pathol. 2004;165:1633-1641.
33. Rankin CT, Bunton T, Lawler AM, Lee SJ. Regulation of left-right patterning in mice by growth/differentiation factor-1. Nat Genet. 2000;24:262-265.
34. Idrees F, Bloch-Zupan A, Free SL, et al. A novel homeobox mutation in the PITX2 gene in a family with Axenfeld-Rieger syndrome associated with brain, ocular, and dental phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2006;141:184-191.
35. Amendt BA, Semina EV, Alward WL. Rieger syndrome: a clinical, molecular, and biochemical analysis. Cell Mol Life Sci. 2000;57:1652-1666.
36. Freely associating (Editorial). Nat Genet. 1999;22:1-2.
37. Reiser BJ, Ignacio TS, Wang Y, et al. In vitro measurement of rabbit corneal epithelial thickness using ultrahigh resolution optical coherence tomography. Vet Ophthalmol. 2005;8:85-88.
38. Grieve K, Paques M, Dubois A, et al. Ocular tissue imaging using ultrahigh-resolution, full-field optical coherence tomography. Invest Ophthalmol Vis Sci. 2004;45:4126-4131.